Prescribing of psychotropic medication to the intellectually disabled by community paediatricians - a survey

S J Elliott1, B B Haider

  • 1The Alders, Birch Avenue, Warrington, Lancashire, UK. sarah.elliot@5bp.nhs.uk

Insights

Community paediatricians frequently prescribe psychotropic medications for children with intellectual disability. Many feel undertrained for ADHD and sleep disorders, highlighting a need for enhanced training and specialist services.

Area of Science:

  • Child and Adolescent Psychiatry
  • Developmental Disabilities
  • Pediatric Psychopharmacology

Background:

  • Children with intellectual disability (ID) often have co-occurring mental health disorders.
  • Community paediatricians manage many of these children.
  • The adequacy of paediatrician training for managing mental health in ID is largely unknown.

Purpose of the Study:

  • To survey psychotropic prescribing practices by community paediatricians for children with ID.
  • To assess paediatricians' perceived training needs in this area.
  • To determine the availability of specialized psychiatric services for this population.

Main Methods:

  • A postal survey was conducted among British Association of Community Child Health members in northern regions.
  • Questionnaires were sent to 155 paediatricians between summer 2004 and autumn 2005.
  • Response rate was 70.1%, with 66 completed questionnaires.

Main Results:

  • Over half (54.5%) of respondents lacked access to specialist child and adolescent psychiatry services for ID.
  • Community paediatricians most commonly prescribed for sleep disorders and attention deficit hyperactivity disorder (ADHD).
  • Perceived training adequacy correlated with prescribing for ADHD, but not for sleep disorders; most felt undertrained for challenging behaviours and depression.

Conclusions:

  • Community paediatricians are significant prescribers of psychotropic medication for children with ID.
  • A notable proportion of paediatricians feel inadequately trained for prescribing for ADHD and sleep disorders.
  • Access to specialist mental health services for children with ID is limited, necessitating service development.
Abstract

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...